Abstract
The majority of patients with chronic renal failure (CRF) undergoing hemodialysis treatment is shown to have hypertriglyceridemia and a high frequency of premature morbidity and mortality from cardiovascular disease1.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
REFERENCE
A.Lindner,B.Charra,D.J.Sherrard and B.H.Scribner,Accelerated atherosclerosis in prolonged maintenance hemodialysis,N.Engl,J.Med.290:679(1974)
B.Lewis,J.Boberg,M.Mancini and L.A.Carlson,Determination of the intravenous fat tolerance test with Intralipid –by nephelometry,Atherosclerosis 15:83(1972)
G.I.Russel,T.G.Davies and J.Walls,Evaluation of the intravenous fat tolerance in chronic renal disease,Clin.Nephrol.13:282(1980)
L.S.Ibels,M.F.Reardon and P.J.Neslel,Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients,J.Lab.Clin.Med.84:684(1976)
E.Savdie,J.E.Mahony and J.H.Stewart,Effect of acetate on serum lipids in maintenance hemodialysis,Trans.Amer.Soc.Artif.Int.Org.23:385(1977)
D.H.Dombeck,D.D.Lindholm and J.A.Vieira,Lipid metabolism in uremia and the effect of dialysate glucose and oral androgen therapy,Trans.Amer. Soc.Artif.Org. 19: 150(1973)
E.Savdie,J.C.Gibson,G.A.Crawford,L.A.Simons and L.F.Mahony,Impaired plasma triglyceride clearance as a feature of both uremic and posttrans- plant triglyceridemia,Kidney Int.18:774(1980)
J.K.Huttunen,A.Pasternak,T.Vänttinen,C.Ehnholm and E.A.Nikkilä,Lipo- protein matabolism in patients with chronic uremia,Acta Med.Scand.204:211(1978)
T.Murase,D.C.Cattran,B.Rubenstein and G.Steiner,Inhibition lipoprotein lipase by uremic plasma, A possible cause hypertriglyceridemia, Metabolism, 24: 2179(1975)
G.G. Guarneri and M.Moracchello,Lecithin cholesterol acyltransferase activity in chronic uremia, Kidney Int.Suppl.No o 8: S26.(1983)
E.Poloyan,J.Kolar,J.Castles,D.Poloyan,P.V.Harper,The role of the parathyroids in lipid metabolism,Fed.Proc.22:676(1963)
M.Cantin,Kidney,Parathyroid and lipemia,Lab.Invest.14:1691(1965)
J.M.Lazarus,E.G.Lowrie,C.L.Hampers and J.P.Merril,Cardiovascular disease in uremic patients on hemodialysis,Kidney Int.7:Suppl,pp.176(1975)
B.Lacour,C.Basile,T.Druek and J-L.F.Brentano,Parathyroid function and lipid metabolism in the rat,Mineral Electrolyte Metab.7:157(1982)
J.Bagdade,E.Yee and 0.J.Pyk‐ list‐,Parathyroid hormone and triglyceride transport:Effects on triglyceride secretion rate and adipose tissue lipoprotein lipase in the rat, Horm. Metab. Res. l0:443(1978)
S.G.Massry,Is parathyroid hormone a uremic toxin ?,Nephron,19:125(1977)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Inoue, S., Fujita, Y., Mori, H., Inagaki, O., Yorifuji, R., Hirabayashi, T. (1989). Studies on the Pathogenesis of Hypertryglyceridemia in Chronic Renal Failure: The Significance of Intravenous Fat Tolerance Test (IVFTT) Before and After Subtotal Parathyroidectomy (PTX). In: Massry, S.G., Fujita, T. (eds) New Actions of Parathyroid Hormone. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0567-5_27
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0567-5_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7870-2
Online ISBN: 978-1-4613-0567-5
eBook Packages: Springer Book Archive